All Stories

  1. A systematic scoping review and gap analysis of questionnaires to assess multimorbidity among children
  2. WHO launches global network of institutes to strengthen capacity for health inequality monitoring
  3. Bacillus anthracis -related knowledge, attitudes, and practices in Koraput, India: A mixed methods study
  4. Long-term humoral and cellular immune responses following Covaxin vaccination: a 2-year prospective longitudinal study
  5. Haemoglobinopathies and health disparities: findings of a large-scale sample survey among indigenous populations in Odisha, India
  6. The magnitude of multimorbidity in childhood: a global systematic review
  7. Effectiveness of single-dose albendazole against soil-transmitted helminth infection in children: A longitudinal study in a tribal dominated district of Odisha, India
  8. Correction: A systematic review and meta-analysis on diagnostic accuracy of point-of-care C-reactive protein devices for acute respiratory tract infections
  9. Development of One Health-based community surveillance system to study zoonotic diseases: a study protocol
  10. Hepatitis B infection status & vaccine coverage among under five children in Mayurbhanj district, Eastern India
  11. Anthrax in Koraput, India: A 15 year retrospective analysis of epidemiological trends, seasonal patterns and vaccine coverage
  12. Multi-Stakeholders’ Perspective on Enhancing Health Literacy for Effective Management of Tuberculosis-Multimorbidity in Odisha, India
  13. Seroprevalence of IgG antibodies against hepatitis-A infection among individuals aged 6–30 years in India, 2021: a nationwide population-based cross-sectional study
  14. Scrub Typhus among Particularly Vulnerable Tribal Groups of Odisha, India
  15. Health-related quality of life among multimorbid patients using the EQ-5D-5L value set for India
  16. Hepatitis B vaccination coverage rates among under-five children in India: a systematic review and meta-analysis protocol
  17. Unraveling the 2023 cholera outbreak in Rourkela municipal corporation of Odisha, India: Antibiotic resistance, virulence factors, and water contamination insights
  18. Prevalence & determinants of soil-transmitted helminth infection among 1-15 year-olds in a tribal-dominated district of Odisha, India
  19. A comprehensive assessment of health indicators among tribal populations in Odisha, India (Odisha Tribal Family Health Survey): a community-based, cross-sectional study
  20. Prevalence and factors associated with tobacco use among pregnant and breastfeeding mothers in India: insights from the National Family Health Survey-5 (2019–21)
  21. Exploring anthrax risk and prevention: A One Health approach for assessment of human, animal, and environmental interactions
  22. Hepatitis B virus infection among children aged 1– 5 years of Mayurbhanj district (Odisha), India: A prospective study protocol
  23. Assessing Hepatitis B virus infection, risk factors and immunization among particularly vulnerable tribal groups in Eastern India
  24. One Health intervention for elimination of animal to human disease transmission of Anthrax in an endemic district of Odisha: A baseline and endline study
  25. An acute diarrheal disease outbreak in urban setting of Odisha, India
  26. Optimal dose and duration of iron supplementation for treating iron deficiency anaemia in children and adolescents: A systematic review and meta-analysis
  27. Molecular simulation of newly designed Mannich-based ciprofloxacin derivative as the promising scaffold for E. coli dihydropteroate synthase and DNA gyrase inhibitor
  28. Microwave-assisted click synthesis, characterisation, and In silico studies of novel 2H-chromene-1,2,3-triazolyl glycoconjugates as potent anticancer and antibacterial agents
  29. Transition Metal‐ and Base‐Free [3 + 2] Cycloaddition: Design, Synthesis, and Antibacterial Activity of Isoxazolidine Derivatives
  30. One health intervention for the control and elimination of scrub typhus, anthrax, and brucellosis in Southeast Asia: a systematic review
  31. Telemedicine-Enabled Otoscopes as Catalysts for Accessible and Preventive Ear Health Care: Systematic Review and Meta-analysis
  32. Cost-effectiveness of portable-automated ABR for universal neonatal hearing screening in India
  33. One Health intervention for elimination of anthrax in an endemic district of Odisha: A baseline and endline study
  34. Social and biological evaluation of antimicrobial resistance (SOBEAR) in rural India: a study protocol
  35. Neutralizing antibody responses to SARS-CoV-2 Omicron variants: Post six months following two-dose & three-dose vaccination of ChAdOx1 nCoV-19 or BBV152
  36. Diagnostic Validation and Feasibility of a Non-invasive Haemoglobin Screening Device (EzeCheck) for 'Anaemia Mukt Bharat' in India
  37. Base catalyzed one-pot thia-Michael addition-oxidation reaction of hetero-aromatic thiols to 2-aryl-3-nitro-2H-chromenes and their antibacterial evaluation
  38. [3+2] Cycloaddition mediated synthesis of spirooxindole pyrrolidine/piperidine fused chromene aldehyde derivatives: DFT studies, antibacterial evaluation and molecular docking investigation as DNA gyrase inhibitors
  39. Suspected human anthrax outbreak investigation in a tribal village of Koraput, India, 2021
  40. Investigation of human anthrax outbreak in Koraput district of Odisha, India
  41. SARS-CoV-2 seroprevalence in patients with autoimmune rheumatic diseases versus family controls: a multi-city cross-sectional survey
  42. Serosurveys to detect SARS-CoV-2 antibodies among high-risk groups in six urban cities of Odisha, India
  43. Non-communicable disease multimorbidity among tribal older adults in India: evidence from Study on Global AGEing and adult health, 2015
  44. Odisha tribal family health survey: methods, tools, and protocols for a comprehensive health assessment survey
  45. Gender differences in COVID-19 knowledge, risk perception, and public stigma among the general community: Findings from a nationwide cross-sectional study in India
  46. Gender dimensions of health-related challenges among urban poor during COVID-19 pandemic in low-and middle-income countries: a systematic review and gap analysis
  47. COVID-19 vaccine hesitancy among school children aged 12-14 years: A cross-sectional study from Bhubaneswar, Odisha, India
  48. Vaccination coverage and breakthrough infections of COVID-19 during the second wave among staff of selected medical institutions in India
  49. Identification of potential inhibitor against CTX-M-3 and CTX-M-15 proteins: an in silico and in vitro study
  50. Hepatitis B virus infection among the tribal and particularly vulnerable tribal population from an eastern state of India: Findings from the serosurvey in seven tribal dominated districts, 2021–2022
  51. Perception and determinants leading to antimicrobial (mis)use: A knowledge, attitude, and practices study in the rural communities of Odisha, India
  52. Effectiveness of the BBV-152 and AZD1222 vaccines among adult patients hospitalized in tertiary hospitals in Odisha with symptomatic respiratory diseases: A test-negative case–control study
  53. Use of Portable Automated Auditory Brainstem Responses in Universal Neonatal Hearing Screening: A Mixed-Method Study in Odisha, India
  54. Access to Maternal and Child Health Services during the COVID-19 Pandemic: An Explorative Qualitative Study in Odisha, India
  55. Outbreaks and sporadic cases of japanese encephalitis in the state of Odisha, India: Outcome of 7 years of laboratory surveillance
  56. Community engagement and involvement in managing the COVID-19 pandemic among urban poor in low-and middle-income countries: a systematic scoping review and stakeholders mapping
  57. Seroprevalence of human brucellosis among the tribal and non-tribal population residing in an eastern state of India: Findings from the state-wide serosurvey
  58. Factors associated with COVID-19 stigma during the onset of the global pandemic in India: A cross-sectional study
  59. Housing-related challenges during COVID-19 pandemic among urban poor in low- and middle-income countries: A systematic review and gap analysis
  60. A Systematic Review of Water, Sanitation, and Hygiene for Urban Poor in Low- and Middle-Income Countries during the COVID-19 Pandemic through a Gendered Lens
  61. Analysis of the COVID-19 testing parameters and progression of the pandemic at the district level: findings from the ICMR Hundred Million Test (HMT) database during the first wave in India
  62. Temporal dynamics of oropharyngeal microbiome among SARS-CoV-2 patients reveals continued dysbiosis even after Viral Clearance
  63. Scrub typhus seroprevalence from an eastern state of India: findings from the state-wide serosurvey
  64. Dynamicity and persistence of severe acute respiratory syndrome coronavirus-2 antibody response after double dose and the third dose with BBV-152 and AZD1222 vaccines: A prospective, longitudinal cohort study
  65. Identification of phytocompounds as newer antiviral drugs against COVID-19 through molecular docking and simulation based study
  66. Effective interventions to ensure MCH (Maternal and Child Health) services during pandemic related health emergencies (Zika, Ebola, and COVID-19): A systematic review
  67. Antibacterial and genotoxic activity of Bixa orellana, a folk medicine and food supplement against multidrug resistant clinical isolates
  68. Impact of smokeless cooking fuel use on health status of women in a rural setting of eastern India
  69. Assessment of socio-behavioural correlates and risk perceptions regarding anthrax disease in tribal communities of Odisha, Eastern India
  70. Resolution of Resilience: Empirical Findings on the Challenges Faced and the Mitigation Strategies Adopted by Community Health Workers (CHWs) to Provide Maternal and Child Health (MCH) Services during the COVID-19 Pandemic in the Context of Odisha, India
  71. Infection, cases due to SARS-CoV-2 in rural areas during early COVID-19 vaccination: findings from serosurvey study in a rural cohort of eastern India
  72. Serological survey for SARS-CoV-2 antibodies among tribal communities of Odisha post-second wave
  73. Trend in seroprevalence of SARS-CoV-2 (IgG antibody) among tribal-dominated population: Findings from Jharkhand, India
  74. Anti-SARS-CoV-2 antibodies among vaccinated healthcare workers: Repeated cross-sectional study
  75. Development & validation of scales to assess stigma related to COVID-19 in India
  76. Effectiveness of introduction of JEV vaccination into routine immunization program in a tribal district of Odisha
  77. Discovery of phyto-compounds as novel inhibitors against NDM-1 and VIM-1 protein through virtual screening and molecular modelling
  78. Persistence of Antibodies Against Spike Glycoprotein of SARS-CoV-2 in Healthcare Workers Post Double Dose of BBV-152 and AZD1222 Vaccines
  79. Re: “Postinfectious Immunity After COVID-19 and Vaccination Against SARS-CoV-2” by Krsak et al.
  80. Single-dose of BBV-152 and AZD1222 increases antibodies against spike glycoprotein among healthcare workers recovered from SARS-CoV-2 infection
  81. COVID-19 in children in Odisha state, India: a retrospective review
  82. Breakthrough SARS‐CoV‐2 infections among BBV‐152 (COVAXIN®) and AZD1222 (COVISHIELD TM ) recipients: Report from the eastern state of India
  83. A systematic review and meta-analysis of screening and diagnostic accuracy for hearing loss among under-five children in South-Asian region
  84. IgG antibody response against nucleocapsid and spike protein post-SARS-CoV-2 infection
  85. SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020–January 2021
  86. Pooled testing for SARS‐CoV‐2 infection in an automated high‐throughput platform
  87. Diagnostic accuracy comparison of three fully automated chemiluminescent immunoassay platforms for the detection of SARS-CoV-2 antibodies
  88. One Health approach for elimination of human anthrax in a tribal district of Odisha: Study protocol
  89. Serological surveys to inform SARS-CoV-2 epidemic curve: a cross-sectional study from Odisha, India
  90. Prevalence and molecular characterization of β-lactamase producers and fluoroquinolone resistant clinical isolates from North East India
  91. Seroprevalence of IgG antibody against SARS-CoV-2 among health care workers of anaesthesia departments from various hospital settings in India
  92. Sequence analysis of Indian SARS-CoV-2 isolates shows a stronger interaction of mutant receptor-binding domain with ACE2
  93. A qualitative exploratory study using One Health approach for developing an intervention package for elimination of human anthrax in an endemic district of Odisha, India
  94. Health system preparedness & community participation in Japanese encephalitis/acute encephalitis syndrome (JE/AES) prevention in a tribal district of Odisha, India
  95. Seroprevalence of SARS-CoV-2 in Bhubaneswar, India: findings from three rounds of community surveys
  96. Saliva for diagnosis of SARS‐CoV‐2: First report from India
  97. Analysis of Indian SARS-CoV-2 Genomes Reveals Prevalence of D614G Mutation in Spike Protein Predicting an Increase in Interaction With TMPRSS2 and Virus Infectivity
  98. SARS-CoV-2 IgG antibody responses in rt-PCR positive cases: first report from India
  99. Stakeholders’ Perspective for Improved Universal Newborn Hearing Screening Uptake in Odisha, India
  100. Saliva as a potential clinical specimen for diagnosis of SARS-CoV-2
  101. The Landscape of Anthrax Prevention and Control: Stakeholders’ Perceptive in Odisha, India
  102. Etiology of Non-Rotaviral Diarrhea in Hospitalized Children Under Five Years of Age
  103. Mapping of Health Technology Assessment (HTA) teaching and training initiatives: Landscape for evidence-based policy decisions in India
  104. Epidemiology of viral disease outbreaks in Odisha, India (2010–2019)
  105. Feasibility of Pooled Testing in a Fully Automated High Throughput Platform for Effective Management of SARS-CoV-2 in India
  106. Etiology of childhood diarrhoea among under five children and molecular analysis of antibiotic resistance in isolated enteric bacterial pathogens from a tertiary care hospital, Eastern Odisha, India
  107. Role of Natural Product in Modulation of Drug Transporters and New Delhi Metallo-β Lactamases
  108. Letters to the Editor
  109. A cross-sectional study on aetiology of diarrhoeal disease, India
  110. Green and ecofriendly synthesis of silver nanoparticles: Characterization, biocompatibility studies and gel formulation for treatment of infections in burns
  111. Vibrio cholerae O1 El Tor variant and emergence of Haitian ctxB variant in the strains isolated from South India
  112. Isolation of NDM-1-producing multidrug-resistant Pseudomonas putida from a paediatric case of acute gastroenteritis, India
  113. Status of hepatitis B infection - a decade after hepatitis B vaccination of susceptible Nicobarese, an indigenous tribe of Andaman & Nicobar (A&N) islands with high hepatitis B endemicity
  114. Transition Densities and Sample Frequency Spectra of Diffusion Processes with Selection and Variable Population Size
  115. Emergence of influenza A (H1N1) PDM09 in the remote Islands of India - A molecular approach
  116. Shewanella algae in acute gastroenteritis
  117. Multidrug-Resistant <i>Vibrio cholerae</i> O1 was Responsible for a Cholera Outbreak in 2013 in Bagalkot, North Karnataka
  118. Occult hepatitis B infection among individuals belonging to the aboriginal Nicobarese tribe of India
  119. Changing patterns and widening of antibiotic resistance inShigellaspp. over a decade (2000–2011), Andaman Islands, India
  120. Prevalence of Mutations in Basal Core Promoter and Precore Region of Hepatitis B Virus in Vaccinated and Nonvaccinated Individuals of the Aboriginal Nicobarese Tribe of Car Nicobar Island, India
  121. Emergence of New Delhi metallo-β-lactamase 1 (NDM-1) Producing and Multidrug Resistant Uropathogens Causing Urinary Tract Infections in Andaman Islands, India
  122. Shigellosis in Bay of Bengal Islands, India: clinical and seasonal patterns, surveillance of antibiotic susceptibility patterns, and molecular characterization of multidrug-resistant Shigella strains isolated during a 6-year period from 2006 to 2011
  123. Emergence of an Unusual Genotype of Rotavirus in Andaman and Nicobar Islands, India
  124. Emergence of Multidrug-Resistant Vibrio cholerae O1 Biotype El Tor in Port Blair, India
  125. High-risk HPV infection among the tribal and non-tribal women of the Andaman and Nicobar Islands, India
  126. Dengue: a newly emerging viral infection in Andaman and Nicobar Islands, India
  127. Isolation and molecular characterization of Chikungunya virus from the Andaman and Nicobar archipelago, India: evidence of an East, Central, and South African genotype
  128. H1N1 influenza A outbreak among the Nicobarese, an aboriginal tribe of the Andaman and Nicobar Islands, India
  129. Third-generation cephalosporin resistance in clinical isolate of Shigella sonnei in Andaman & Nicobar Islands, India
  130. Prevalence of the plasmid-mediated quinolone resistance determinants among clinical isolates of Shigella sp. in Andaman & Nicobar Islands, India
  131. Rapid Emergence of Third-Generation Cephalosporin Resistance in Shigella Sp. Isolated in Andaman and Nicobar Islands, India
  132. Acute Diarrhea in Children after 2004 Tsunami, Andaman Islands